Since 2009 the GRASSP has been available to the SCI community for use.
The GRASSP Inventors group have created a tiered licensing process that is managed by Commercialize at UHN (formerly the UHN Business and Technology Transfer Office). The representative that you can reach out to directly is Laura Farran, Laura.Farran@uhn.ca.
The licensing system is designed to ensure there is a fair opportunity to all parties choosing to use GRASSP in their work. The licensing process is a separate process from the purchase of GRASSP kits. Please read the tiers below to understand within which category your research falls into.
Clinical License for the individual purchasing of the product. This agreement is executed online when the GRASSP is purchased. There is no fee for this license, only that the purchaser is aware that the use of the GRASSP Kit they are purchasing is meant for clinical implementation. The purchaser will not collect data for a sponsored driven study within this agreement.
Academic License for use within an investigator driven study, that is or is not funded by a not for profit granting foundation/agency. This license can apply to primary investigators, graduate students, academic institutions, research institutes and healthcare institutes. There is no fee for this license, however, a data sharing agreement is required. Commercialize at UHN will execute the license. The de-identified GRASSP data collected in the study will be requested at the end of the study. The data transfer agreement (DTA) will be executed by the KITE Research Institute-UHN. The specific data elements that will be requested will be included in the DTA.
Industry License for a company or for-profit organization conducting any developmental research, a study or trial. This license requires a fee which is executed with Commercialize at UHN.
Private Healthcare Institutes using GRASSP as a part of the medical record or charging a third party to provide GRASSP results. This license requires a fee which is executed with Commercialize at UHN. The fees are based on size of institute, usage and renewal terms.
GRASSP digitization and addition to electronic health records. This license is executed by Commercialize at UHN. This license is required by both publicly funded and private institutes that wish to include GRASSP in the digital patient chart. Both the institute and vendor of EMR digitization is required to have a license and terms for use.
A translation license must be negotiated before with Commercialize at UHN prior to translation. A person or group is welcome to translate GRASSP to the language of choice for use in their institute and among their team. The final version of the translation must be provided to
Neural Outcomes Consulting Inc. Distribution of all translations is done only by Neural Outcomes Consulting Inc. A translation licensee is NOT permitted to distribute the translated version. All GRASSP materials have been developed in Canadian English. If you require any GRASSP materials to be translated into any language reach out directly to Mr. Timothy Ryan available at email@example.com and Laura Farran firstname.lastname@example.org.
Translation of GRASSP written materials policy:
All GRASSP materials have been developed in Canadian English. Translations for academic/clinical use can be done with permission, a specific Tier 2 license is required in order to execute this process. Contact Drs Kalsi-Ryan email@example.com and Laura Farran firstname.lastname@example.org to establish and execute the translation agreement. Once the translation is completed ownership will remain with the GRASSP Research and Design Group and distribution of the translated materials will be executed by NOCI only.
Current Translations Available:
GRASSP Version 1 Manual: Available in English and French Canadian
GRASSP Version 2 Manual: Available in English, German, Italian, Spanish and Czech